Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

Overview of attention for article published in Journal of Neuroinflammation, November 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#28 of 2,765)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 11 news stories from 11 outlets.

Esta investigación abre posibilidades al tratamiento de la enfermedad basado en la medicina personalizada Un nuevo trabajo…

Un nuevo trabajo realizado por el Laboratorio de Neuroinmuno-Reparación del Hospital Nacional de Parapléjicos, centro…

Investigadores del Hospital de Parapléjicos Demuestran que las células mieloides supresoras periféricas (MDSCs) son un buen…

Demuestran que las células mieloides supresoras periféricas (MDSCs) son un buen marcador de respuesta y eficacia al medicamento…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 7 additional news stories.